Jonathan Levitt, Author at Frier Levitt

Pharmacy Alert: Be Aware of Deadlines set by Express Scripts, Inc. to Appeal Absence of Prescriber-Patient Relationship Denials, As Well as New Documentation Required to Appeal

Diana Ryzhova, Esq., Jesse C. Dresser, Esq., Kendra E. Pannitti, Esq. and Jonathan Levitt December 1, 2020

Express Scripts, Inc. (“ESI”), has switched gears once again in its recoupment efforts that originally began on April 7, 2020, and re-initiated by ESI on September 1, 2020 . ESI unilaterally recoups funds from pharmacies based on an alleged... Read More

PBM Licensure and Regulation Model Act

Martha M. Rumore Pharm.D., Esq., Jesse C. Dresser, Esq. and Jonathan Levitt November 30, 2020

The current United States marketplace for the regulation of pharmacy benefits is a patchwork of inconsistent (and in some cases non-existent) state laws, state and federal agency regulations, agency manuals and federal laws. Uniform state laws would... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | Life Sciences | Plan Sponsor PBM Contract Services

What Happens If a Loved One Passed From COVID-19 Related Care?

Jonathan Levitt, Michelle L. Greenberg, Esq. and Christopher Caltavuturo, Esq. September 4, 2020

Over 185,000 Americans and counting have lost their lives battling COVID-19. Health care providers have fought hard for patients and the Government has granted them, along with vaccine manufacturers, broad immunity from liability. However, victims... Read More

COVID-19 Resources

Why Filing MAC Appeals Should be a “Win-Win” for Pharmacies

Lucas W. Morgan, Esq. and Jonathan Levitt June 17, 2020

Pharmacy Benefit Managers (PBMs) Maximum Allowable Cost or “MAC” pricing continues to be one of the most challenging issues facing independent pharmacies throughout the United States—MAC is one of the primary ways in which PBMs reimburse... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | Maximum Allowable Cost Pricing & Appeals | Pharmacy Law

Frier Levitt Alternative Fee Arrangements and Challenging DIR fees During COVID-19

Jonathan Levitt and Lucas W. Morgan, Esq. April 6, 2020

As COVID-19 grips the national economy, pharmacies are not immune from the financial fallout. Challenging PBMs’ abusive DIR fee recoupments is more important than ever to preserve the viability of independent pharmacy. As pharmacies struggle to... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law

Author: Jonathan Levitt

Pharmacy Alert: Be Aware of Deadlines set by Express Scripts, Inc. to Appeal Absence of Prescriber-Patient Relationship Denials, As Well as New Documentation Required to Appeal

What Happens If a Loved One Passed From COVID-19 Related Care?

Why Filing MAC Appeals Should be a “Win-Win” for Pharmacies

Frier Levitt Alternative Fee Arrangements and Challenging DIR fees During COVID-19

Value Based Care insights

Let us help you find solutions.

Sign up for our newsletter

Author: Jonathan Levitt

Pharmacy Alert: Be Aware of Deadlines set by Express Scripts, Inc. to Appeal Absence of Prescriber-Patient Relationship Denials, As Well as New Documentation Required to Appeal

PBM Licensure and Regulation Model Act

What Happens If a Loved One Passed From COVID-19 Related Care?

Jonathan Levitt, Jesse Dresser and Dae Lee Author article for Managed Healthcare Executive

Why Filing MAC Appeals Should be a “Win-Win” for Pharmacies

Frier Levitt Alternative Fee Arrangements and Challenging DIR fees During COVID-19

Value Based Care insights

Let us help you find solutions.

Sign up for our newsletter